100 FIFTH AVENUE, WALTHAM, MA
News, Reorganization Plan
Mikael Dolsten Elected to Board of Directors at Apellis Pharmaceuticals
Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
Material Contracts
Shareholder votes
Annual Report to Security Holders
Changes in Board, Management or Compensation
Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference
FY 2024
Q3
Q2
Q1
FY 2023
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Submission Upload
Correspondence